{"id":9905,"date":"2025-05-26T20:23:24","date_gmt":"2025-05-26T20:23:24","guid":{"rendered":"https:\/?page_id=9905"},"modified":"2025-06-06T17:13:30","modified_gmt":"2025-06-06T17:13:30","slug":"allergy-and-immunology-2","status":"publish","type":"page","link":"https:\/\/eutranslationalmedicine.org\/aii\/allergy-and-immunology-2\/","title":{"rendered":"Allergy and Immunology"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\n\t\t\t\n\t\t\t\t\t\t
\n\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAllergy and Immunology\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/h1>\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The fields of allergy and immunology are rapidly evolving with breakthroughs in targeted biologics, immunomodulators, and desensitization therapies. Companies are advancing new treatments for allergic diseases, atopic conditions, and immune dysregulation by leveraging deep immunological insights. These innovations are helping patients achieve long-term relief, improved quality of life, and in some cases, disease modification.<\/p>

Key Focus Areas<\/b>:<\/h5>

\u00a0<\/p>

  • Biologic Therapies for Allergic and Atopic Diseases<\/strong>
    Targeting IgE, IL-4, IL-5, IL-13, and IL-31 to reduce inflammation and hypersensitivity in asthma, atopic dermatitis, and chronic urticaria.<\/p><\/li>

  • Allergen-Specific Immunotherapy (AIT)<\/strong>
    Sublingual (SLIT), subcutaneous (SCIT), and epicutaneous desensitization platforms for treating food, environmental, and venom allergies.<\/p><\/li>

  • Monoclonal Antibodies for Severe Asthma & Eosinophilic Conditions<\/strong>
    Anti-IL-5, anti-IL-5R, anti-IL-13, and anti-TSLP antibodies reducing eosinophil-driven inflammation in asthma and EGIDs.<\/p><\/li>

  • Novel Cytokine and Receptor Blockers<\/strong>
    Targeting Th2 cytokines and their receptors to rebalance immune signaling in allergic diseases.<\/p><\/li>

  • Peanut & Food Allergy Therapies<\/strong>
    Standardized oral immunotherapy (OIT), biologics, and next-generation antigen-specific desensitization platforms.<\/p><\/li>

  • Immune Tolerance Induction<\/strong>
    Therapeutic strategies aimed at retraining the immune system to stop recognizing allergens as threats.<\/p><\/li>

  • JAK Inhibitors for Atopic Dermatitis<\/strong>
    Oral and topical agents targeting JAK1\/2 to suppress cytokine signaling involved in skin inflammation.<\/p><\/li>

  • Microbiome Modulation in Allergy<\/strong>
    Investigational approaches restoring microbial balance to prevent or treat allergic conditions, particularly in early childhood.<\/p><\/li>

  • Mast Cell & Basophil Stabilization<\/strong>
    Small molecules and antibodies to block histamine release and allergic mediator activity.<\/p><\/li>

  • Biomarker-Based Stratification<\/strong>
    Identification of endotypes and predictive biomarkers to tailor therapies in asthma and chronic rhinosinusitis.<\/p><\/li>

  • Others<\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

    The fields of allergy and immunology are rapidly evolving with breakthroughs in targeted biologics, immunomodulators, and desensitization therapies. Companies are advancing new treatments for allergic diseases, atopic conditions, and immune dysregulation by leveraging deep immunological insights. These innovations are helping patients achieve long-term relief, improved quality of life, and in some cases, disease modification. Key […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-9905","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nAllergy and Immunology - Alliance for Immunology Innovations (AII)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eutranslationalmedicine.org\/aii\/allergy-and-immunology-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Allergy and Immunology - Alliance for Immunology Innovations (AII)\" \/>\n<meta property=\"og:description\" content=\"The fields of allergy and immunology are rapidly evolving with breakthroughs in targeted biologics, immunomodulators, and desensitization therapies. Companies are advancing new treatments for allergic diseases, atopic conditions, and immune dysregulation by leveraging deep immunological insights. These innovations are helping patients achieve long-term relief, improved quality of life, and in some cases, disease modification. Key […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eutranslationalmedicine.org\/aii\/allergy-and-immunology-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Alliance for Immunology Innovations (AII)\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-06T17:13:30+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/aii\\\/allergy-and-immunology-2\\\/\",\"url\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/aii\\\/allergy-and-immunology-2\\\/\",\"name\":\"Allergy and Immunology - Alliance for Immunology Innovations (AII)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/aii\\\/#website\"},\"datePublished\":\"2025-05-26T20:23:24+00:00\",\"dateModified\":\"2025-06-06T17:13:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/aii\\\/allergy-and-immunology-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eutranslationalmedicine.org\\\/aii\\\/allergy-and-immunology-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/aii\\\/allergy-and-immunology-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/aii\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Allergy and Immunology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/aii\\\/#website\",\"url\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/aii\\\/\",\"name\":\"Alliance for Immunology Innovations (AII)\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eutranslationalmedicine.org\\\/aii\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Allergy and Immunology - Alliance for Immunology Innovations (AII)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eutranslationalmedicine.org\/aii\/allergy-and-immunology-2\/","og_locale":"en_US","og_type":"article","og_title":"Allergy and Immunology - Alliance for Immunology Innovations (AII)","og_description":"The fields of allergy and immunology are rapidly evolving with breakthroughs in targeted biologics, immunomodulators, and desensitization therapies. Companies are advancing new treatments for allergic diseases, atopic conditions, and immune dysregulation by leveraging deep immunological insights. These innovations are helping patients achieve long-term relief, improved quality of life, and in some cases, disease modification. Key […]","og_url":"https:\/\/eutranslationalmedicine.org\/aii\/allergy-and-immunology-2\/","og_site_name":"Alliance for Immunology Innovations (AII)","article_modified_time":"2025-06-06T17:13:30+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/eutranslationalmedicine.org\/aii\/allergy-and-immunology-2\/","url":"https:\/\/eutranslationalmedicine.org\/aii\/allergy-and-immunology-2\/","name":"Allergy and Immunology - Alliance for Immunology Innovations (AII)","isPartOf":{"@id":"https:\/\/eutranslationalmedicine.org\/aii\/#website"},"datePublished":"2025-05-26T20:23:24+00:00","dateModified":"2025-06-06T17:13:30+00:00","breadcrumb":{"@id":"https:\/\/eutranslationalmedicine.org\/aii\/allergy-and-immunology-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eutranslationalmedicine.org\/aii\/allergy-and-immunology-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/eutranslationalmedicine.org\/aii\/allergy-and-immunology-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eutranslationalmedicine.org\/aii\/"},{"@type":"ListItem","position":2,"name":"Allergy and Immunology"}]},{"@type":"WebSite","@id":"https:\/\/eutranslationalmedicine.org\/aii\/#website","url":"https:\/\/eutranslationalmedicine.org\/aii\/","name":"Alliance for Immunology Innovations (AII)","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eutranslationalmedicine.org\/aii\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/eutranslationalmedicine.org\/aii\/wp-json\/wp\/v2\/pages\/9905","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eutranslationalmedicine.org\/aii\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/eutranslationalmedicine.org\/aii\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/eutranslationalmedicine.org\/aii\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eutranslationalmedicine.org\/aii\/wp-json\/wp\/v2\/comments?post=9905"}],"version-history":[{"count":8,"href":"https:\/\/eutranslationalmedicine.org\/aii\/wp-json\/wp\/v2\/pages\/9905\/revisions"}],"predecessor-version":[{"id":10052,"href":"https:\/\/eutranslationalmedicine.org\/aii\/wp-json\/wp\/v2\/pages\/9905\/revisions\/10052"}],"wp:attachment":[{"href":"https:\/\/eutranslationalmedicine.org\/aii\/wp-json\/wp\/v2\/media?parent=9905"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}